Physician profile
Vojtech Slezka
NPI 1073500286
$3,872.66
in general payments reported to CMS, 2019-2025
25 companies · $557 in 2025
The $557 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,624 · 2020: $373 · 2021: $324 · 2022: $400 · 2023: $279 · 2024: $316 · 2025: $557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,152.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $587.99 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $527.88 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $471.19 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $374.36 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $338.90 | 2019-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $319.72 | 2021-2025 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $299.86 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $186.44 | 2019-2025 | Lokelma, Farxiga, Brilinta |
| Boston Scientific Corporation | $155.36 | 2019-2022 | |
| Abbott Laboratories | $88.62 | 2019-2025 | Aveir, Jot Dx |
| Biotronik INC. | $68.47 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $62.39 | 2019-2025 | Lifevest |
| Regeneron Healthcare Solutions, INC. | $53.99 | 2019 | |
| Sanofi-Aventis U.S. LLC | $50.82 | 2019 | |
| Amarin Pharma, INC. | $37.91 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $35.59 | 2024-2025 | Wegovy |
| Medtronic Vascular, INC. | $29.69 | 2019-2020 | |
| Abiomed | $26.87 | 2025 | |
| Edwards Lifesciences Corporation | $25.03 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic, INC. | $24.42 | 2024 | Cobalt Dr Mri Surescan |
| Lilly USA, LLC | $23.36 | 2025 | Zepbound |
| Astellas Pharma US INC | $21.23 | 2019 | |
| Scpharmaceuticals INC. | $21.06 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $20.82 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.69 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vojtech Slezka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.